Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$0.48.

  • Legend Biotech's EPS (Weighted Average and Diluted) was N/A to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.42, marking a year-over-year change of. This contributed to the annual value of -$0.48 for FY2024, which is 67.35% up from last year.
  • As of FY2024, Legend Biotech's EPS (Weighted Average and Diluted) stood at -$0.48, which was up 67.35% from -$1.47 recorded in FY2023.
  • Legend Biotech's 5-year EPS (Weighted Average and Diluted) high stood at -$0.48 for FY2024, and its period low was -$1.47 during FY2023.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$1.12, with a median of -$1.40 in 2022.
  • As far as peak fluctuations go, Legend Biotech's EPS (Weighted Average and Diluted) crashed by 121.57% in 2020, and later skyrocketed by 67.35% in 2024.
  • Legend Biotech's EPS (Weighted Average and Diluted) (Yearly) stood at -$1.13 in 2020, then decreased by 26.55% to -$1.43 in 2021, then grew by 2.10% to -$1.40 in 2022, then dropped by 5.00% to -$1.47 in 2023, then skyrocketed by 67.35% to -$0.48 in 2024.